| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.3 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |